Clinical Trails to Evaluate H5N1 Influenza Variant Vaccines

NIH RePORTER · NIH · N01 · $7,985,002 · view on reporter.nih.gov ↗

Abstract

The current influenza H5N1 outbreak is an ongoing public health situation that has been observed in various regions throughout the US. H5N1 is a highly pathogenic avian influenza virus that primarily affects birds but can also infect other animals, including cattle (bovine H5N1). The objective of this Task Order supports NIAID’s goal to conduct phase 1 and phase 2 trials on H5N1 influenza vaccines to generate data to inform decisions on which candidates to support for advanced development.

Key facts

NIH application ID
11210622
Project number
75N91019D00024-0-759102400032-1
Recipient
LEIDOS BIOMEDICAL RESEARCH, INC.
Principal Investigator
THERESA ENGEL
Activity code
N01
Funding institute
NIH
Fiscal year
2024
Award amount
$7,985,002
Award type
Project period
2024-09-09 → 2027-09-08